Fotemustine

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Key facts

Fotemustine is a drug catalogued in DrugCentral.

• ATC code: L01AD05 (Nitrosoureas).
• Molecular formula: C9H19ClN3O5P; molecular weight 315.69 g/mol.

ATC classification

ATC code	Therapeutic hierarchy
L01AD05	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › ALKYLATING AGENTS › Nitrosoureas

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Acute myeloid leukaemia	99.5
Tonsillar haemorrhage	80.1
Disease progression	77.3
Diffuse large B-cell lymphoma recurrent	69.4
Mucosal inflammation	56.6

Chemical structure

• Molecular formula: C₉H₁₉ClN₃O₅P
• Molecular weight: 315.69 g/mol
• CAS number: —
• InChIKey: YAKWPXVTIGTRJH-UHFFFAOYSA-N
• PubChem CID: 104799

CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Fotemustine?

Fotemustine has the molecular formula C9H19ClN3O5P and a molecular weight of 315.69 g/mol.

Sources

• DrugCentral drug card 1249 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL549386 — compound record and bioactivity
• PubChem CID 104799 — chemical identifiers
• DrugBank DB04106 — drug record
• FDA UNII GQ7JL9P5I2 — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.